John P. Leonard, MD, Weill Cornell Medicine

Articles by John P. Leonard, MD, Weill Cornell Medicine

Selecting CAR T-Cell Therapies for R/R DLBCL

ByDavid Rizzieri, MD,John P. Leonard, MD, Weill Cornell Medicine,Greg Nowakowski, MD

August 11th 2021

Experts discuss the use and selection of CAR T therapies in relapsed/refractory diffuse large B-cell lymphoma.

DLBCL Second-Line Therapy Recommendations

ByJohn P. Leonard, MD, Weill Cornell Medicine,Loretta Nastoupil, MD,David Rizzieri, MD,Cyrus Khan, MD

July 28th 2021

Experts discussed their recommendations for second-line treatment options for patients with DLBCL.

Dr. Leonard on Emergence of CAR T-cell Therapy in Hematologic Cancers

ByJohn P. Leonard, MD, Weill Cornell Medicine

May 5th 2017

John P. Leonard, MD, associate dean of Clinical Research, interim chair of the Department of Medicine, Weill Cornell Medical College, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies.